Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children. American Thoracic Society and the Centers for Disease Control and Prevention
1994885 citationsJohn B. Bass, Laurence S. Farer et al.American Journal of Respiratory and Critical Care Medicineprofile →
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1991646 citationsAlan B. Bloch, Dixie E. Snider et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Dixie E. Snider
Since
Specialization
Citations
This map shows the geographic impact of Dixie E. Snider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dixie E. Snider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dixie E. Snider more than expected).
This network shows the impact of papers produced by Dixie E. Snider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dixie E. Snider. The network helps show where Dixie E. Snider may publish in the future.
Co-authorship network of co-authors of Dixie E. Snider
This figure shows the co-authorship network connecting the top 25 collaborators of Dixie E. Snider.
A scholar is included among the top collaborators of Dixie E. Snider based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Dixie E. Snider. Dixie E. Snider is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Kilburn, J O, et al.. (2015). A Continuing Survey of Tuberculosis Primary Drug Resistance in the United States: March 1975 to November 1977. American Review of Respiratory Disease.
2.
O’Brien, Richard, Lawrence Geiter, & Dixie E. Snider. (2015). The Epidemiology of Nontuberculous Mycobacterial Diseases in the United States. American Review of Respiratory Disease.14 indexed citations
3.
Snider, Dixie E., et al.. (2015). Isoniazid-Related Hepatitis. American Review of Respiratory Disease.1 indexed citations
4.
Snider, Dixie E., et al.. (2015). A Continuing Survey of Primary Drug Resistance in Tuberculosis, 1961 to 1968. American Review of Respiratory Disease.
5.
Marin, Mona, Karen R. Broder, Jonathan L. Temte, Dixie E. Snider, & Jane F. Seward. (2010). Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).. PubMed. 59(RR-3). 1–12.91 indexed citations
Bloch, Alan B., Ida M. Onorato, Walter Ihle, et al.. (1996). The need for epidemic intelligence.. PubMed. 111(1). 26–31; discussion 32.18 indexed citations
Bass, John B., Laurence S. Farer, Philip C. Hopewell, et al.. (1994). Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children. American Thoracic Society and the Centers for Disease Control and Prevention. American Journal of Respiratory and Critical Care Medicine. 149(5). 1359–1374.885 indexed citations breakdown →
Glassroth, Jeffrey, Dixie E. Snider, & G W Comstock. (1977). Urinary tract cancer and isoniazid.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(2). 331–3.8 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.